Hasil Pencarian - P.R. Carroll
- Menampilkan 1 - 8 hasil dari 8
-
1
Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset oleh P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg
Diterbitkan 2020-07-01
Artikel -
2
-
3
-
4
-
5
Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer oleh V. Fasulo, C.M. De La Calle, J.E. Cowan, A. Herlemann, C.E. Chu, A.J. Gadzinsky, R.A. Yeung, A. Saita, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen
Diterbitkan 2020-07-01
Artikel -
6
Evaluation of the 4K score and MRI for the detection of high-grade prostate cancer oleh V. Fasulo, C.M. De La Calle, J.E. Cowan, A. Herlemann, C.E. Chu, A.J. Gadzinsky, R.A. Yeung, A. Saita, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen
Diterbitkan 2020-07-01
Artikel -
7
Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer oleh V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen
Diterbitkan 2020-10-01
Artikel -
8
Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial oleh J. Ferdinandus, W.P. Fendler, J. Calais, M. Eiber, R.R. Flavell, A. Mishoe, F.Y. Feng, H.G. Nguyen, R.E. Reiter, M.B. Rettig, J. Gartmann, R. Smith, E.J. Small, R. Slavik, P.R. Carroll, K. Herrmann, J. Czernin, T.A. Hope
Diterbitkan 2020-07-01
Artikel